Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families

被引:39
作者
Lahti-Domenici, J
Rapakko, K
Pääkkönen, K
Allinen, M
Nevanlinna, H
Kujala, M
Huusko, P
Winqvist, R
机构
[1] Oulu Univ, Cent Hosp, Dept Clin Genet, FIN-90220 Oulu, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oncol & Radiotherapy, Helsinki, Finland
[3] Oulu Univ, Cent Hosp, Dept Obstet & Gynecol, FIN-90220 Oulu, Finland
基金
芬兰科学院;
关键词
D O I
10.1016/S0165-4608(01)00437-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the Finnish population, identified mutations in BRCA1 and BRCA2 account for a less than expected proportion of hereditary breast and ovarian cancer. All previous studies performed in our country have concentrated on finding germ-line mutations in the coding and splice-site regions of these two genes. Therefore. we wanted to use a different methodological approach and search for large genomic rearrangements. to exclude the possibility of biased BRCA1 and BRCA2 mutation spectra due to known limitations of the previously used PCR-based detection methods. Our results support earlier notions that other genes than BRCA1 and BRCA2 will explain a majority of the still unexplained cases of hereditary susceptibility to breast and ovarian cancer. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 19 条
[1]   DISEASE GENE-MAPPING IN ISOLATED HUMAN-POPULATIONS - THE EXAMPLE OF FINLAND [J].
DELACHAPELLE, A .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (10) :857-865
[2]   Evidence of founder mutations in Finnish BRCA1 and BRCA2 families [J].
Huusko, P ;
Pääkkönen, K ;
Launonen, V ;
Pöyhönen, M ;
Blanco, G ;
Kauppila, A ;
Puistola, U ;
Kiviniemi, H ;
Kujala, M ;
Leisti, J ;
Winqvist, R .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1544-1548
[3]   Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2 [J].
Huusko, P ;
Castrén, K ;
Launonen, V ;
Soini, Y ;
Pääkkönen, K ;
Leisti, J ;
Vähäkangas, K ;
Winqvist, R .
CANCER GENETICS AND CYTOGENETICS, 1999, 112 (01) :9-14
[4]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[5]   Transcriptional activation functions in BRCA2 [J].
Milner, J ;
Ponder, B ;
HughesDavies, L ;
Seltmann, M ;
Kouzarides, T .
NATURE, 1997, 386 (6627) :772-773
[6]  
Nordling M, 1998, CANCER RES, V58, P1372
[7]  
Payne SR, 2000, GENE CHROMOSOME CANC, V29, P58, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1008>3.0.CO
[8]  
2-F
[9]   Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families [J].
Peelen, T ;
van Vliet, M ;
Bosch, A ;
Bignell, G ;
Vasen, HFA ;
Klijn, JGM ;
Meijers-Heijboer, H ;
Stratton, M ;
van Ommen, GJB ;
Cornelisse, CJ ;
Devilee, P .
BRITISH JOURNAL OF CANCER, 2000, 82 (01) :151-156
[10]   BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients [J].
PetrijBosch, A ;
Peelen, T ;
vanVliet, M ;
vanEijk, R ;
Olmer, R ;
Drusedau, M ;
Hogervorst, FBL ;
Hageman, S ;
Arts, PJW ;
Ligtenberg, MJL ;
MeijersHeijboer, H ;
Klijn, JGM ;
Vasen, HFA ;
Cornelisse, CJ ;
vantVeer, LJ ;
Bakker, E ;
vanOmmen, GJB ;
Devilee, P .
NATURE GENETICS, 1997, 17 (03) :341-345